Literature DB >> 19443133

Interim methadone treatment: impact on arrests.

Robert P Schwartz1, Jerome H Jaffe, Kevin E O'Grady, Timothy W Kinlock, Michael S Gordon, Sharon M Kelly, Monique E Wilson, Ashraf Ahmed.   

Abstract

AIMS: This study examines the frequency and severity of arrest charges among heroin addicts randomly assigned to either interim methadone (IM) maintenance or to remain on a waiting list for methadone treatment. It was hypothesized that IM participants would have a: (1) lower number of arrests at 6 and 12 months and (2) lower mean crime severity scores at 6 and 12 months post-baseline.
METHODS: Available official arrest data were obtained for all 319 study participants for a period of 2 years before and after study enrollment. Crime severity ratings of charges were made using an established measure of crime severity.
FINDINGS: Participants randomly assigned to IM as compared to those on a waiting list had a significant reduction in number of arrests at 6 but not at 12 months from study enrollment. There were no significant differences in whether participants were arrested for a more severe crime but frequency of severe crime was relatively low in both groups. Additional post hoc analyses based on whether participants were in methadone treatment at 4 and 10 months after original random assignment to treatment condition revealed that those participants not in treatment at these follow-up assessment points were significantly more likely to be arrested and to have a higher mean crime severity rating at 12 and 24 months post-baseline assessment.
CONCLUSIONS: IM as compared to the waiting list condition, had a significant reduction in number of officially recorded arrests from baseline to 6 months post-baseline. Those who were enrolled in methadone treatment at the 4- and 10-month follow-up assessment, regardless of initial assignment, had fewer arrests at 12 and 24 months post-baseline.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443133      PMCID: PMC2699328          DOI: 10.1016/j.drugalcdep.2009.03.007

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  28 in total

1.  Changes in criminal activity after entering methadone maintenance.

Authors:  J Bell; W Hall; K Byth
Journal:  Br J Addict       Date:  1992-02

2.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

Review 3.  Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance.

Authors:  M Rosenbaum; A Washburn; K Knight; M Kelley; J Irwin
Journal:  J Psychoactive Drugs       Date:  1996 Jul-Sep

4.  A 48-week study of methadone, methadyl acetate, and minimal services. 1974 [proceedings].

Authors:  E C Senay; J H Jaffe; S Dimenza; P F Renault
Journal:  NIDA Res Monogr       Date:  1976-07

5.  Arrests before and during methadone maintenance.

Authors:  C L Bowden; J F Maddux; M Esquivel
Journal:  Int J Addict       Date:  1978-08

6.  Heroin addiction treatment and crime reduction.

Authors:  R L Dupont
Journal:  Am J Psychiatry       Date:  1972-01       Impact factor: 18.112

7.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

8.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

9.  Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

Authors:  Marina Davoli; Anna M Bargagli; Carlo A Perucci; Patrizia Schifano; Valeria Belleudi; Matthew Hickman; Giuseppe Salamina; Roberto Diecidue; Federica Vigna-Taglianti; Fabrizio Faggiano
Journal:  Addiction       Date:  2007-12       Impact factor: 6.526

10.  A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.

Authors:  Valerie A Gruber; Kevin L Delucchi; Anousheh Kielstein; Steven L Batki
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

View more
  27 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Ukrainian prisoners and community reentry challenges: implications for transitional care.

Authors:  Olga Morozova; Lyuba Azbel; Yevgeny Grishaev; Sergii Dvoryak; Jeffrey A Wickersham; Frederick L Altice
Journal:  Int J Prison Health       Date:  2013

3.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

4.  Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2018-11-19

Review 5.  Opioid dependence.

Authors:  K Thyarappa Praveen; Fergus Law; Jacinta O'Shea; Jan Melichar
Journal:  BMJ Clin Evid       Date:  2011-09-20

6.  When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.

Authors:  Robert P Schwartz
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

7.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

8.  Interim methadone treatment compared to standard methadone treatment: 4-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-02-24

9.  Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.

Authors:  Michael S Gordon; Frank J Vocci; Terrence T Fitzgerald; Kevin E O'Grady; Charles P O'Brien
Journal:  Contemp Clin Trials       Date:  2016-12-20       Impact factor: 2.226

10.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.